- Home
- ACHC vs BHC Comparison
ACHC vs BHC Comparison
Compare ACHC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- BHC
- Stock Information
- Founded
- ACHC 2005
- BHC N/A
- Country
- ACHC United States
- BHC Canada
- Employees
- ACHC N/A
- BHC N/A
- Industry
- ACHC Medical Specialities
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ACHC Health Care
- BHC Health Care
- Exchange
- ACHC Nasdaq
- BHC Nasdaq
- Market Cap
- ACHC 2.1B
- BHC 1.7B
- IPO Year
- ACHC N/A
- BHC N/A
- Fundamental
- Price
- ACHC $22.64
- BHC $4.53
- Analyst Decision
- ACHC Buy
- BHC Hold
- Analyst Count
- ACHC 9
- BHC 5
- Target Price
- ACHC $47.94
- BHC $7.20
- AVG Volume (30 Days)
- ACHC 2.4M
- BHC 1.5M
- Earning Date
- ACHC 05-12-2025
- BHC 04-30-2025
- Dividend Yield
- ACHC N/A
- BHC N/A
- EPS Growth
- ACHC N/A
- BHC N/A
- EPS
- ACHC 2.04
- BHC N/A
- Revenue
- ACHC $3,156,417,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- ACHC $7.86
- BHC $3.71
- Revenue Next Year
- ACHC $8.55
- BHC $5.03
- P/E Ratio
- ACHC $11.10
- BHC N/A
- Revenue Growth
- ACHC 5.48
- BHC 8.53
- 52 Week Low
- ACHC $20.36
- BHC $3.96
- 52 Week High
- ACHC $82.41
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ACHC 40.69
- BHC 39.91
- Support Level
- ACHC $22.30
- BHC $4.50
- Resistance Level
- ACHC $23.58
- BHC $4.61
- Average True Range (ATR)
- ACHC 1.21
- BHC 0.13
- MACD
- ACHC -0.11
- BHC 0.03
- Stochastic Oscillator
- ACHC 7.59
- BHC 21.30
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.